Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
Authors
Keywords
-
Journal
mBio
Volume 12, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2021-03-01
DOI
10.1128/mbio.00230-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
- (2021) Kathryn A. Ryan et al. Nature Communications
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Potential association between COVID-19 mortality and health-care resource availability
- (2020) Yunpeng Ji et al. Lancet Global Health
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
- (2020) Young-Il Kim et al. Cell Host & Microbe
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
- (2020) Su-Jin Park et al. mBio
- Recent Progress on the Versatility of Virus-Like Particles
- (2020) Ciying Qian et al. Vaccines
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Distinct conformational states of SARS-CoV-2 spike protein
- (2020) Yongfei Cai et al. SCIENCE
- Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation
- (2020) Hannah G. Kelly et al. JCI Insight
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
- (2020) Bingfeng Liu et al. Cellular & Molecular Immunology
- Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2
- (2020) Vivek Gupta et al. CLINICAL INFECTIOUS DISEASES
- Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
- (2020) Kelvin Kai-Wang To et al. CLINICAL INFECTIOUS DISEASES
- Long-term Health Consequences of COVID-19
- (2020) Carlos del Rio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
- (2020) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- (2020) Richard L Tillett et al. LANCET INFECTIOUS DISEASES
- Long-term consequences of COVID-19: research needs
- (2020) Dana Yelin et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
- (2020) Nicholas C. Wu et al. Cell Reports
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
- (2020) Erik Volz et al. CELL
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus
- (2019) Myung Hee Kim et al. PLoS One
- Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
- (2018) Norbert Pardi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection
- (2018) Kok Fei Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
- (2018) Young-Seok Kim et al. Frontiers in Immunology
- Virus-like particle vaccines: immunology and formulation for clinical translation
- (2018) Braeden Donaldson et al. Expert Review of Vaccines
- Pathogenesis, humoral immune responses and transmission between co-housed animals in a ferret model of human RSV infection.
- (2017) Kok Fei Chan et al. JOURNAL OF VIROLOGY
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
- (2017) Xiajun Hu et al. Scientific Reports
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
- (2016) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells
- (2016) Jidnyasa Ingale et al. Cell Reports
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Ferritin family proteins and their use in bionanotechnology
- (2015) Didi He et al. New Biotechnology
- Ferret models of viral pathogenesis
- (2015) T. Enkirch et al. VIROLOGY
- Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
- (2014) Ding Yuan Oh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The C-Terminal Regions Have an Important Role in the Activity of the Ferroxidase Center and the Stability of Chlorobium tepidum Ferritin
- (2014) Cristian Brito et al. PROTEIN JOURNAL
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine
- (2012) Cuiming Zhu et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
- (2012) A. Link et al. JOURNAL OF IMMUNOLOGY
- Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection
- (2012) Fangliu Yu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model
- (2012) Mark J. Cameron et al. PLoS One
- Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines
- (2012) Shibo Jiang et al. Emerging Microbes & Infections
- Effects of Different Adjuvants in the Context of Intramuscular and Intranasal Routes on Humoral and Cellular Immune Responses Induced by Detergent-Split A/H3N2 Influenza Vaccines in Mice
- (2011) Mariana Baz et al. Clinical and Vaccine Immunology
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- The Crystal Structure of Ferritin from Helicobacter pylori Reveals Unusual Conformational Changes for Iron Uptake
- (2009) Ki Joon Cho et al. JOURNAL OF MOLECULAR BIOLOGY
- The SARS-CoV ferret model in an infection–challenge study
- (2008) Yong-Kyu Chu et al. VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now